Reference ranges for blood tests
Template:Short description Template:Reference ranges Reference ranges (reference intervals) for blood tests are sets of values used by a health professional to interpret a set of medical test results from blood samples. Reference ranges for blood tests are studied within the field of clinical chemistry (also known as "clinical biochemistry", "chemical pathology" or "pure blood chemistry"), the area of pathology that is generally concerned with analysis of bodily fluids.[1][2][3]
Blood test results should always be interpreted using the reference range provided by the laboratory that performed the test.[4]
Interpretation
A reference range is usually defined as the set of values 95 percent of the normal population falls within (that is, 95% prediction interval).[5] It is determined by collecting data from vast numbers of laboratory tests.[6][7]
Plasma or whole blood
In this article, all values (except the ones listed below) denote blood plasma concentration, which is approximately 60–100% larger than the actual blood concentration if the amount inside red blood cells (RBCs) is negligible. The precise factor depends on hematocrit as well as amount inside RBCs. Exceptions are mainly those values that denote total blood concentration, and in this article they are:[8]
- All values in Hematology – red blood cells (except hemoglobin in plasma)
- All values in Hematology – white blood cells
- Platelet count (Plt)
A few values are for inside red blood cells only:
- Vitamin B9 (folic acid/folate) in red blood cells
- Mean corpuscular hemoglobin concentration (MCHC)
Units
- Mass concentration (g/dL or g/L) is the most common measurement unit in the United States. Is usually given with dL (decilitres) as the denominator in the United States, and usually with L (litres) in, for example, Sweden.Template:Cn
- Molar concentration (mol/L) is used to a higher degree in most of the rest of the world, including the United Kingdom and other parts of Europe and Australia and New Zealand.[9]
- International units (IU) are based on measured biological activity or effect, or for some substances, a specified equivalent mass.Template:Cn
- Enzyme activity (kat) is commonly used for e.g. liver function tests like AST, ALT, LD and γ-GT in Sweden.[10]
- Percentages and time-dependent units (mol/s) are used for calculated derived parameters, e.g. for beta cell function in homeostasis model assessment or thyroid's secretory capacity.[11]
Arterial or venous
If not otherwise specified, a reference range for a blood test is generally the venous range, as the standard process of obtaining a sample is by venipuncture. An exception is for acid–base and blood gases, which are generally given for arterial blood.[12]
Still, the blood values are approximately equal between the arterial and venous sides for most substances, with the exception of acid–base, blood gases and drugs (used in therapeutic drug monitoring (TDM) assays).[13] Arterial levels for drugs are generally higher than venous levels because of extraction while passing through tissues.[13]
Usual or optimal
Reference ranges are usually given as what are the usual (or normal) values found in the population, more specifically the prediction interval that 95% of the population fall into. This may also be called standard range. In contrast, optimal (health) range or therapeutic target is a reference range or limit that is based on concentrations or levels that are associated with optimal health or minimal risk of related complications and diseases. For most substances presented, the optimal levels are the ones normally found in the population as well. More specifically, optimal levels are generally close to a central tendency of the values found in the population. However, usual and optimal levels may differ substantially, most notably among vitamins and blood lipids, so these tables give limits on both standard and optimal (or target) ranges. In addition, some values, including troponin I and brain natriuretic peptide, are given as the estimated appropriate cutoffs to distinguish healthy people from people with specific conditions, which here are myocardial infarction and congestive heart failure, respectively, for the aforementioned substances.[14][15][16]
Variability
Template:Further References range may vary with age, sex, race, pregnancy,[17] diet, use of prescribed or herbal drugs and stress. Reference ranges often depend on the analytical method used, for reasons such as inaccuracy, lack of standardisation, lack of certified reference material and differing antibody reactivity.[18] Also, reference ranges may be inaccurate when the reference groups used to establish the ranges are small.[19]
Sorted by concentration
By mass and molarity
Smaller, narrower boxes indicate a more tight homeostatic regulation when measured as standard "usual" reference range. Template:Blood Values
Hormones predominate at the left part of the scale, shown with a red at ng/L or pmol/L, being in very low concentration. There appears to be the greatest cluster of substances in the yellow part (μg/L or nmol/L), becoming sparser in the green part (mg/L or μmol/L). However, there is another cluster containing many metabolic substances like cholesterol and glucose at the limit with the blue part (g/L or mmol/L).Template:Cn
The unit conversions of substance concentrations from the molar to the mass concentration scale above are made as follows:
- Numerically:
- Measured directly in distance on the scales:
- ,
where distance is the direct (not logarithmic) distance in number of decades or "octaves" to the right the mass concentration is found. To translate from mass to molar concentration, the dividend (molar mass and the divisor (1000) in the division change places, or, alternatively, distance to right is changed to distance to left. Substances with a molar mass around 1000g/mol (e.g. thyroxine) are almost vertically aligned in the mass and molar images. Adrenocorticotropic hormone, on the other hand, with a molar mass of 4540,[20] is 0.7 decades to the right in the mass image. Substances with molar mass below 1000g/mol (e.g. electrolytes and metabolites) would have "negative" distance, that is, masses deviating to the left. Many substances given in mass concentration are not given in molar amount because they haven't been added to the article.
The diagram above can also be used as an alternative way to convert any substance concentration (not only the normal or optimal ones) from molar to mass units and vice versa for those substances appearing in both scales, by measuring how much they are horizontally displaced from one another (representing the molar mass for that substance), and using the same distance from the concentration to be converted to determine the equivalent concentration in terms of the other unit. For example, on a certain monitor, the horizontal distance between the upper limits for parathyroid hormone in pmol/L and pg/mL may be 7 cm, with the mass concentration to the right. A molar concentration of, for example, 5 pmol/L would therefore correspond to a mass concentration located 7 cm to the right in the mass diagram, that is, approximately 45 pg/mL.
By units
Units do not necessarily imply anything about molarity or mass.

A few substances are below this main interval, e.g. thyroid stimulating hormone, being measured in mU/L, or above, like rheumatoid factor and CA19-9, being measured in U/mL.
By enzyme activity

White blood cells

Sorted by category
Ions and trace metals
Template:Further Included here are also related binding proteins, like ferritin and transferrin for iron, and ceruloplasmin for copper.
- Note: Although 'mEq' for mass and 'mEq/L' are sometimes used in the United States and elsewhere, they are not part of SI and are now considered redundant.
Acid–base and blood gases
Template:Further Template:Further If arterial/venous is not specified for an acid–base or blood gas value, then it generally refers to arterial, and not venous which otherwise is standard for other blood tests.Template:Cn
Acid–base and blood gases are among the few blood constituents that exhibit substantial difference between arterial and venous values.[13] Still, pH, bicarbonate and base excess show a high level of inter-method reliability between arterial and venous tests, so arterial and venous values are roughly equivalent for these.[51]
| Test | Arterial/Venous | Lower limit | Upper limit | Unit |
|---|---|---|---|---|
| pH | Arterial | 7.34,[22] 7.35[21] | 7.44,[22] 7.45[21] | |
| Venous | 7.31[52] | 7.41[52] | ||
| [H+] | Arterial | 36[21] | 44[21] | nmol/L |
| 3.6[53] | 4.4[53] | ng/dL | ||
| Base excess | Arterial & venous[52] | −3[52] | +3[52] | mEq/L |
| Oxygen partial pressure (pO2) | Arterial pO2 | 10,[21] 11[54] | 13,[54] 14[21] | kPa |
| 75,[21][22] 83[30] | 100,[22] 105[21] | mmHg or torr | ||
| Venous | 4.0[54] | 5.3[54] | kPa | |
| 30[52] | 40[52] | mmHg or torr | ||
| Oxygen saturation | Arterial | 94,[52] 95,[25] 96[30] | 100[25][30] | % |
| Venous | Approximately 75[25] | |||
| Carbon dioxide partial pressure (pCO2) | Arterial PaCO2 | 4.4,[21] 4.7[54] | 5.9,[21] 6.0[54] | kPa |
| 33,[21] 35[22] | 44,[21] 45[22] | mmHg or torr | ||
| Venous | 5.5,[54] | 6.8[54] | kPa | |
| 41[52] | 51[52] | mmHg or torr | ||
| Absolute content of carbon dioxide (CO2) | Arterial | 23[52] | 30[52] | mmol/L |
| 100[55] | 132[55] | mg/dL | ||
| Bicarbonate (HCO3−) | Arterial & venous | 18[30] | 23[30] | mmol/L |
| 110[56] | 140[56] | mg/dL | ||
| Standard bicarbonate (SBCe) | Arterial & venous | 21, 22[21] | 27, 28[21] | mmol/L or mEq/L[21] |
| 134[56] | 170[56] | mg/dL | ||
Liver function
| Test | Patient type | Lower limit | Upper limit | Unit | Comments |
|---|---|---|---|---|---|
| Total protein (TotPro) | 60,[21] 63[22] | 78,[21] 82,[22] 84[30] | g/L | See serum total protein Interpretation | |
| Albumin | 35[21][57] | 48,[22] 55[21] | g/L | See hypoalbuminemia | |
| 3.5[22] | 4.8,[22] 5.5[21] | U/L | |||
| 540[58] | 740[58] | μmol/L | |||
| Globulins | 23[21] | 35[21] | g/L | ||
| Template:Anchor Total bilirubin | 1.7,[59] 2,[21] 3.4,[59] 5[10] | 17,[21][59] 22,[59] 25[10] | μmol/L | ||
| 0.1,[21] 0.2,[22] 0.29[60] | 1.0,[21][30] 1.3,[22] 1.4[60] | mg/dL | |||
| Direct/conjugated bilirubin | 0.0[21] or N/A[10] | 5,[21] 7[10][59] | μmol/L | ||
| 0[21][22] | 0.3,[21][22] 0.4[30] | mg/dL | |||
| Alanine transaminase (ALT/ALAT[10]) | 5,[61] 7,[22] 8[21] | 20,[21] 21,[25] 56[22] | U/L | Also called serum glutamic pyruvic transaminase (SGPT) | |
| Female | 0.15[10] | 0.75[10] | μkat/L | ||
| Male | 0.15[10] | 1.1[10] | |||
| Aspartate transaminase (AST/ASAT[10]) | Female | 6[62] | 34[62] | IU/L | Also called serum glutamic oxaloacetic transaminase (SGOT) |
| 0.25[10] | 0.60[10] | μkat/L | |||
| Male | 8[62] | 40[62] | IU/L | ||
| 0.25[10] | 0.75[10] | μkat/L | |||
| Alkaline phosphatase (ALP) | 0.6[10] | 1.8[10] | μkat/L | ||
| Female | 42[61] | 98[61] | U/L | ||
| Male | 53[61] | 128[61] | |||
| Gamma glutamyl transferase (GGT) | 5,[61] 8[22] | 40,[61] 78[22] | U/L | ||
| Female | 0.63[63] | μkat/L | |||
| Male | 0.92[63] | μkat/L |
Cardiac tests
| Test | Patient type | Lower limit | Upper limit | Unit | Comments |
|---|---|---|---|---|---|
| Creatine kinase (CK) | Male | 24,[64] 38,[22] 60[61] | 174,[30] 320[61] | U/L or ng/mL | |
| 0.42[65] | 1.5[65] | μkat/L | |||
| Female | 24,[64] 38,[22] 96[30] | 140,[30] 200[61] | U/L or ng/mL | ||
| 0.17[65] | 1.17[65] | μkat/L | |||
| CK-MB | 0 | 3,[22] 3.8,[10] 5[61] | ng/mL or μg/L[10] | ||
| Myoglobin | Female | 1[66] | 66[66] | ng/mL or μg/L | |
| Male | 17[66] | 106[66] | |||
| Cardiac troponin T (low sensitive) | 0.1[14] | ng/mL | 99th percentile cutoff | ||
| Cardiac troponin I
(high sensitive) |
0.03[14] | ng/mL | 99th percentile cutoff | ||
| Cardiac troponin T (high sensitive) | Male | 0.022[14] | ng/mL | 99th percentile cutoff | |
| Female | 0.014[14] | ng/mL | 99th percentile cutoff | ||
| newborn/infants | not established | more than adults [67][68] |
| Brain natriuretic peptide (BNP) Template:Hatnote | |
| Interpretation | Range / Cutoff |
|---|---|
| Congestive heart failure unlikely | < 100 pg/mL[15][16] |
| "Gray zone" | 100–500 pg/mL[15][16] |
| Congestive heart failure likely | > 500 pg/mL[15][16] |
| NT-proBNP Template:Hatnote | ||
| Interpretation | Age | Cutoff |
|---|---|---|
| Congestive heart failure likely | < 75 years | > 125 pg/mL[69] |
| > 75 years | > 450pg/mL[69] | |
Lipids
| Test | Patient type | Lower limit | Upper limit | Unit | Therapeutic target |
|---|---|---|---|---|---|
| Triglycerides | 10–39 years | 54[30] | 110[30] | mg/dL | < 100 mg/dL[70] or 1.1 mmol/L[70] |
| 0.61[71] | 1.2[71] | mmol/L | |||
| 40–59 years | 70[30] | 150[30] | mg/dL | ||
| 0.77[71] | 1.7[71] | mmol/L | |||
| > 60 years | 80[30] | 150[30] | mg/dL | ||
| 0.9[71] | 1.7[71] | mmol/L | |||
| Total cholesterol | 3.0,[72] 3.6[21][72] | 5.0,[10][73] 6.5[21] | mmol/L | < 3.9 mmol/L[70] | |
| 120,[22] 140[21] | 200,[22] 250[21] | mg/dL | < 150 mg/dL[70] | ||
| HDL cholesterol | Female | 1.0,[74] 1.2,[10] 1.3[72] | 2.2[74] | mmol/L | > 1.0[74] or 1.6[72] mmol/L 40[75] or 60[76] mg/dL |
| 40,[75] 50[77] | 86[75] | mg/dL | |||
| HDL cholesterol | Male | 0.9[10][74] | 2.0[74] | mmol/L | |
| 35[75] | 80[75] | mg/dL | |||
| LDL cholesterol (Not valid when triglycerides >5.0 mmol/L) |
2.0,[74] 2.4[73] | 3.0,[10][73] 3.4[74] | mmol/L | < 2.5 mmol/L[74] | |
| 80,[75] 94[75] | 120,[75] 130[75] | mg/dL | < 100 mg/dL[75] | ||
| LDL/HDL quotient | n/a | 5[10] | (unitless) |
Tumour markers
| Test | Patient type | Cutoff | Unit | Comments |
|---|---|---|---|---|
| Alpha fetoprotein (AFP) | 44[22] | ng/mL or μg/L | Hepatocellular carcinoma or testicular cancer | |
| Beta human chorionic gonadotrophin (β-hCG) | In males and non-pregnant females | 5[22] | IU/L or mU/mL | choriocarcinoma |
| CA19-9 | 40[22] | U/mL | Pancreatic cancer | |
| CA-125 | 30,[78] 35[79] | kU/L or U/mL | ||
| Carcinoembryonic antigen (CEA) | Non-smokers, 50 years | 3.4,[10] 3.6[80] | μg/L | |
| Non-smokers, 70 years | 4.1[80] | |||
| Smokers | 5[81] | |||
| Prostate specific antigen (PSA) | 40–49 years | 1.2–2.9[82] | μg/L[10][22] or ng/mL[30] | More detailed cutoffs in PSA – Serum levels |
| 70–79 years, non-African-American | 4.0–9.0[82] | |||
| 70–79 years, African-American | 7.7–13[82] | |||
| PAP | 3[30] | units/dL (Bodansky units) | ||
| Calcitonin | 5,[83] 15[83] | ng/L or pg/mL | Cutoff against medullary thyroid cancer[83] More detailed cutoffs in Calcitonin article |
Endocrinology
Thyroid hormones
| Test | Patient type | Lower limit | Upper limit | Unit |
|---|---|---|---|---|
| Thyroid stimulating hormone (TSH or thyrotropin) |
Adults – standard range |
0.3,[10] 0.4,[22] 0.5,[30] 0.6[84] | 4.0,[10] 4.5,[22] 6.0[30] | mIU/L or μIU/mL |
| Adults – optimal range |
0.3,[85] 0.5[86] | 2.0,[86] 3.0[85] | ||
| Infants | 1.3[87] | 19[87] | ||
| Free thyroxine (FT4) Template:Hatnote |
Normal adult | 0.7,[88] 0.8[22] | 1.4,[88] 1.5,[22] 1.8[89] | ng/dL |
| 9,[10][90] 10,[91] 12[92] | 18,[10][90] 23[92] | pmol/L | ||
| Child/Adolescent 31 d – 18 y |
0.8[88] | 2.0[88] | ng/dL | |
| 10[90] | 26[90] | pmol/L | ||
| Pregnant | 0.5[88] | 1.0[88] | ng/dL | |
| 6.5[90] | 13[90] | pmol/L | ||
| Total thyroxine | 4,[91] 5.5[22] | 11,[91] 12.3[22] | μg/dL | |
| 60[91][92] | 140,[91] 160[92] | nmol/L | ||
| Free triiodothyronine (FT3) | Normal adult | 0.2[91] | 0.5[91] | ng/dL |
| 3.1[93] | 7.7[93] | pmol/L | ||
| Children 2-16 y | 0.1[94] | 0.6[94] | ng/dL | |
| 1.5[93] | 9.2[93] | pmol/L | ||
| Total triiodothyronine | 60,[22] 75[91] | 175,[91] 181[22] | ng/dL | |
| 0.9,[10] 1.1[91] | 2.5,[10] 2.7[91] | nmol/L | ||
| Thyroxine-binding globulin (TBG) | 12[22] | 30[22] | mg/L | |
| Thyroglobulin (Tg) | 1.5[91] | 30[91] | pmol/L | |
| 1[91] | 20[91] | μg/L |
Sex hormones
Template:Further The diagrams below take inter-cycle and inter-woman variability into account in displaying reference ranges for estradiol, progesterone, FSH and LH.

| Test | Patient type | Lower limit | Upper limit | Unit |
|---|---|---|---|---|
| Dihydrotestosterone | adult male | 1.0[96] | 2.9[97] | nmol/L |
| 30 | 85 | ng/dL | ||
| Testosterone | Male, overall | 8,[98] 10[99] | 27,[98] 35[99] | nmol/L |
| 230,[100] 300[101] | 780–1000[100][101] | ng/dL | ||
| Male < 50 years | 10[10] | 45[10] | nmol/L | |
| 290[100] | 1300[100] | ng/dL | ||
| Male > 50 years | 6.2[10] | 26[10] | nmol/L | |
| 180[100] | 740[100] | ng/dL | ||
| Female | 0.7[99] | 2.8–3.0[99][10] | nmol/L | |
| 20[101] | 80–85[101][100] | ng/dL | ||
| 17α-Hydroxyprogesterone | male | 0.06[30] | 3.0[30] | mg/L |
| 0.18[102] | 9.1[102] | μmol/L | ||
| Female (Follicular phase) | 0.2[30] | 1.0[30] | mg/L | |
| 0.6[102] | 3.0[102] | μmol/L | ||
| Follicle-stimulating hormone (FSH) Template:Hatnote |
Prepubertal | <1[103] | 3[103] | IU/L |
| Adult male | 1[103] | 8[103] | ||
| Adult female (follicular and luteal phase) |
1[103] | 11[103] | ||
| Adult female (Ovulation) | 6[103] 95% PI (standard) |
26[103] 95% PI) | ||
| 5[104] 90% PI (used in diagram) |
15[104] (90% PI) | |||
| Post-menopausal female | 30[103] | 118[103] | ||
| Luteinizing hormone (LH) Template:Hatnote |
Female, peak | 20[104] 90% PI (used in diagram) |
75[104] (90% PI) |
IU/L |
| Female, post-menopausal | 15[105] | 60[105] | ||
| Male aged 18+ | 2[106] | 9[106] | ||
| Estradiol (an estrogen) Template:Hatnote |
Adult male | 50[107] | 200[107] | pmol/L |
| 14[108] | 55[108] | pg/mL | ||
| Adult female (day 5 of follicular phase, and luteal phase) |
70[107] | 500,[107] 600[107] | pmol/L | |
| 19[108] | 140,[108] 160[108] | pg/mL | ||
| Adult female – free (not protein bound) | 0.5[109] | 9[109] | pg/mL | |
| 1.7[109] | 33[109] | pmol/L | ||
| Post-menopausal female | 0[107] | 130[107] | pmol/L | |
| 0[108] | 35[108] | pg/mL | ||
| Progesterone Template:Hatnote |
Female in mid-luteal phase (day 21–23) | 17,[104] 35[110] | 92[110] | nmol/L |
| 6,[104] 11[111] | 29[111] | ng/mL | ||
| Androstenedione | Adult male and female | 60[105] | 270[105] | ng/dL |
| Post-menopausal female | < 180[105] | |||
| Prepubertal | < 60[105] | |||
| Dehydroepiandrosterone sulfate Template:Hatnote | Adult male and female | 30[112] | 400[112] | μg/dL |
| SHBG Template:Hatnote |
Adult female | 40[113] | 120[113] | nmol/L |
| Adult male | 20[113] | 60[113] | ||
| Anti-Müllerian hormone (AMH) Template:Hatnote |
13–45 years | 0.7[114] | 20[114] | ng/mL |
| 5[115] | 140[115] | pmol/L |
Other hormones
Vitamins
Also including the vitamin B12)-related amino acid homocysteine.
| Test | Patient type | Standard range | Optimal range | Unit | ||
|---|---|---|---|---|---|---|
| Lower limit | Upper limit | Lower limit | Upper limit | |||
| Vitamin A | 30[30] | 65[30] | μg/dL | |||
| Vitamin B9 (Folic acid/Folate) – Serum |
Age > 1 year | 3.0[135] | 16[135] | 5[136] | ng/mL or μg/L | |
| 6.8[137] | 36[137] | 11[137] | nmol/L | |||
| Vitamin B9 (Folic acid/Folate) – Red blood cells |
200[135] | 600[135] | ng/mL or μg/L | |||
| 450[137] | 1400[137] | nmol/L | ||||
| Pregnant | 400[135] | ng/mL or μg/L | ||||
| 900[135] | nmol/L | |||||
| Vitamin B12 (Cobalamin) | 130,[138] 160[139] | 700,[138] 950[139] | ng/L | |||
| 100,[140] 120[10] | 520,[140] 700[10] | pmol/L | ||||
| Homocysteine Template:Hatnote |
3.3,[141] 5.9[141] | 7.2,[141] 15.3[141] | 6.3[70] | μmol/L | ||
| 45,[142] 80[142] | 100,[142] 210[142] | 85[70] | μg/dL | |||
| Vitamin C (Ascorbic acid) | 0.4[30] | 1.5[30] | 0.9[70] | mg/dL | ||
| 23[143] | 85[143] | 50[70] | μmol/L | |||
| 25-hydroxycholecalciferol (a vitamin D) | 8,[30][124] 9[124] | 40,[124] 80[30] | 30,[127] 40[128] | 65,[128] 100[127] | ng/mL | |
| 20,[125] 23[126] | 95,[126] 150[125] | 85,[70] 100[128] | 120,[70] 160[128] | nmol/L | ||
| Vitamin E | 28[70] | μmol/L | ||||
| 1.2[70] | mg/dL | |||||
Toxic Substances
| Test | Limit type | Limit | Unit |
|---|---|---|---|
| Lead | Optimal health range | < 20[25] or 40[30] | μg/dL |
| Blood ethanol content | Limit for drunk driving | 0,[144] 0.2,[144] 0.8[144] | ‰ or g/L |
| 17.4[145] | mmol/L |
Hematology
Red blood cells
These values (except Hemoglobin in plasma) are for total blood and not only blood plasma.
| Test | Patient | Lower limit | Upper limit | Unit | Comments |
|---|---|---|---|---|---|
| Hemoglobin (Hb) | Male | 2.0,[146] 2.1[21][147] | 2.5,[146] 2.7[21][147] | mmol/L | Higher in neonates, lower in children. |
| 130,[10] 132,[22] 135[21] | 162,[22] 170,[10] 175[21] | g/L | |||
| Female | 1.8,[146] 1.9[21][147] | 2.3,[146] 2.5[21][146][147] | mmol/L | Sex difference negligible until adulthood. | |
| 120[10][21][22] | 150,[10] 152,[22] 160[21][30] | g/L | |||
| Hemoglobin subunits (sometimes displayed simply as "Hemoglobin") | Male | 8.0,[148] 8.4[148] | 10.0,[148] 10.8[148] | mmol/L | 4 per hemoglobin molecule |
| Female | 7.2,[148] 7.6[148] | 9.2,[148] 10.0[148] | |||
| Hemoglobin in plasma | 0.16[21] | 0.62[21] | μmol/L | Normally diminutive compared with inside red blood cells | |
| 1 | 4 | mg/dL | |||
| Glycated hemoglobin (HbA1c) | < 50 years | 3.6[10] | 5.0[10] | % of Hb | |
| > 50 years | 3.9[10] | 5.3[10] | |||
| Haptoglobin | < 50 years | 0.35[10] | 1.9[10] | g/L | |
| > 50 years | 0.47[10] | 2.1[10] | |||
| Hematocrit (Hct) | Male | 0.39,[10] 0.4,[22] 0.41,[21] 0.45[30] | 0.50,[10] 0.52,[22] 0.53,[21] 0.62[30] | L/L | |
| Female | 0.35,[10] 0.36,[21] 0.37[22][30] | 0.46,[10][21][22] 0.48[30] | L/L | ||
| Child | 0.31[22] | 0.43[22] | L/L | ||
| Mean corpuscular volume (MCV) | Male | 76,[30] 82[22] | 100,[30] 102[22] | fL | Cells are larger in neonates, though smaller in other children. |
| Female | 78[22] | 101[22] | fL | ||
| Red blood cell distribution width (RDW) | 11.5[22] | 14.5[22] | % | ||
| Mean cell hemoglobin (MCH) | 0.39[21] | 0.54[21] | fmol/cell | ||
| 25,[21] 27[10][30] | 32,[30] 33,[10] 35[21] | pg/cell | |||
| Mean corpuscular hemoglobin concentration (MCHC) | 4.8,[149] 5.0[149] | 5.4,[149] 5.6[149] | mmol/L | ||
| 31,[22] 32[10][30] | 35,[22] 36[10][30] | g/dL or %[note 1] | |||
| Erythrocytes/Red blood cells (RBC) | Male | 4.2,[30] 4.3[10][21][22] | 5.7,[10] 5.9,[21] 6.2,[22] 6.9[30] | ×1012/L or million/mm3 |
|
| Female | 3.5,[21] 3.8,[22] 3.9[10] | 5.1,[10] 5.5[21][22] | |||
| Infant/Child | 3.8[22] | 5.5[22] | |||
| Reticulocytes | Adult | 26[10] | 130[10] | ×109/L | |
| 0.5[21][22] | 1.5[21][22] | % of RBC | |||
| Newborn | 1.1[22] | 4.5[22] | % of RBC | ||
| Infant | 0.5[22] | 3.1[22] | % of RBC | ||
| Immature reticulocyte fraction (IRF) | Adult | 1.6[150] | 12.1[150] | % of reticulocytes | |
| Reticulocyte hemoglobin equivalent | Adult | 30.0[150] | 37.6[150] | % | |
| 24.1[151] | 35.8[151] | pg | |||
| Immature platelet fraction (IPF) | Adult | 0.8[150] | 5.6[150] | % |
White blood cells
These values are for total blood and not only blood plasma.
| Test | Patient type | Lower limit | Upper limit | Unit |
|---|---|---|---|---|
| White Blood Cell Count (WBC) | Adult | 3.5,[10] 3.9,[152] 4.1,[22] 4.5[21] | 9.0,[10] 10.0,[152] 10.9,[22] 11[21] |
|
| Newborn | 9[153] | 30[153] | ||
| 1 year old | 6[153] | 18[153] | ||
| Template:Anchor Neutrophil granulocytes (A.K.A. grans, polys, PMNs, or segs) |
Adult | 1.3,[10] 1.8,[152] 2[153] | 5.4,[10] 7,[152] 8[153] | ×109/L |
| 45–54[21] | 62,[21] 74 | % of WBC | ||
| Newborn | 6[153] | 26[153] | ×109/L | |
| Neutrophilic band forms | Adult | 0.7[153] | ×109/L | |
| 3[21] | 5[21] | % of WBC | ||
| Lymphocytes | Adult | 0.7,[10] 1.0[152][153] | 3.5,[152] 3.9,[10] 4.8[153] | ×109/L |
| 16–25[21] | 33,[21] 45 | % of WBC | ||
| Newborn | 2[153] | 11[153] | ×109/L | |
| Monocytes | Adult | 0.1,[10] 0.2[154][155] | 0.8[10][153][155] | ×109/L |
| 3,[21] 4.0 | 7,[21] 10 | % of WBC | ||
| Newborn | 0.4[153] | 3.1[153] | ×109/L | |
| Mononuclear leukocytes (Lymphocytes + monocytes) |
Adult | 1.5 | 5 | ×109/L |
| 20 | 35 | % of WBC | ||
| CD4+ T cells | Adult | 0.4,[22] 0.5[25] | 1.5,[25] 1.8[22] | ×109/L |
| Eosinophil granulocytes | Adult | 0.0,[10] 0.04[155] | 0.44,[155] 0.45,[153] 0.5[10] | ×109/L |
| 1[21] | 3,[21] 7 | % of WBC | ||
| Newborn | 0.02[153] | 0.85[153] | ×109/L | |
| Basophil granulocytes | Adult | 40[152] | 100,[10][155] 200,[153] 900[152] | ×106/L |
| 0.0 | 0.75,[21] 2 | % of WBC | ||
| Newborn | 0.64[153] | ×109/L |
Coagulation
| Test | Lower limit | Upper limit | Unit | Comments |
|---|---|---|---|---|
| Thrombocyte/Platelet count (Plt) | 140,[22] 150[10][21] | 350,[10][30] 400,[21] 450[22] | ×109/L or x1000/μL |
|
| Mean platelet volume (MPV) | 7.2,[156] 7.4,[157] 7.5[158] | 10.4,[157] 11.5,[158] 11.7[156] | fL | |
| Prothrombin time (PT) | 10,[25] 11,[21][159] 12[22] | 13,[25] 13.5,[159] 14,[22] 15[21] | s | PT reference varies between laboratory kits – INR is standardised |
| INR | 0.9[10] | 1.2[10] | The INR is a corrected ratio of a patient's PT to normal | |
| Activated partial thromboplastin time (APTT) | 18,[22] 30[10][25] | 28,[22] 42,[10] 45[25] | s | |
| Thrombin clotting time (TCT) | 11 | 18 | s | |
| Fibrinogen | 1.7,[22] 2.0[10] | 3.6,[10] 4.2[22] | g/L | |
| Antithrombin | 0.80[10] | 1.2[10] | kIU/L | |
| 0.15,[160] 0.17[161] | 0.2,[160] 0.39[161] | mg/mL | ||
| Bleeding time | 2 | 9 | minutes | |
| Viscosity | 1.5[162] | 1.72[162] | cP |
Immunology
Acute phase proteins
Acute phase proteins are markers of inflammation.
| Test | Patient | Lower limit | Upper limit | Unit | Comments |
|---|---|---|---|---|---|
| Erythrocyte sedimentation rate (ESR) |
Male | 0 | Age÷2[163] | mm/h | ESR increases with age and tends to be higher in females.[164] |
| Female | (Age+10)÷2[163] | ||||
| C-reactive protein (CRP) | 5,[10][165] 6[166] | mg/L | |||
| 200,[167] 240[167] | nmol/L | ||||
| Alpha 1-antitrypsin (AAT) | 20,[168] 22[169] | 38,[169] 53[168] | μmol/L | ||
| 89,[170] 97[10] | 170,[10] 230[170] | mg/dL | |||
| Procalcitonin | 0.15[171] | ng/mL or μg/L |
Isotypes of antibodies
| Test | Patient | Lower limit | Upper limit | Unit |
|---|---|---|---|---|
| IgA | Adult | 70,[10] 110[172] | 360,[10] 560[172] | mg/dL |
| IgD | 0.5[172] | 3.0[172] | ||
| IgE | 0.01[172] | 0.04[172] | ||
| IgG | 800[172] | 1800[172] | ||
| IgM | 54[172] | 220[172] |
Autoantibodies
Template:For Autoantibodies are usually absent or very low, so instead of being given in standard reference ranges, the values usually denote where they are said to be present, or whether the test is a positive test. There may also be an equivocal interval, where it is uncertain whether there is a significantly increased level.
| Test | Negative | Equivocal | Positive | Unit |
|---|---|---|---|---|
| anti-SS-A (Ro) | < 1.0[173] | n/a | ≥ 1.0[173] | Units (U) |
| anti-SS-B (La) | < 1.0[174] | n/a | ≥ 1.0[174] | |
| Anti ds-DNA | < 30.0[175] | 30.0–75.0[175] | > 75.0[175] | International Units per millilitre (IU/mL) |
| Anti ss-DNA | < 8[176] | 8–10[176] | > 10[176] | Units per millilitre (U/mL) |
| Anti-histone antibodies | < 25[176] | n/a[176] | > 25[176] | |
| Cytoplasmic anti-neutrophil cytoplasmic antibodies (c-ANCA) |
< 20[176] | 21–30[176] | > 30[176] | |
| Perinuclear anti-neutrophil cytoplasmic antibodies (p-ANCA) |
< 5[176] | n/a | > 5[176] | |
| Anti-mitochondrial antibodies (AMA) | < 0.1[177] | 0.1-0.9[177] | ≥ 1.0[177] | Units (U) |
| Rheumatoid factor (RF) | < 20 | 20–30 | > 30[22] | Units per millilitre (U/mL) |
| Antistreptolysin O titre (ASOT) in preschoolers |
> 100 | |||
| ASOT at school age | > 250[22] | |||
| ASOT in adults | > 125[22] |
| Test | Negative | Low/weak positive | Moderate positive | High/strong positive | Unit |
|---|---|---|---|---|---|
| Anti-phospholipid IgG | < 20[176] | 20–30[176] | 31–50[176] | > 51[176] | GPLU/mL[176] |
| Anti-phospholipid IgM | < 1.5[176] | 1.5–2.5[176] | 2–9.9[176] | > 10[176] | MPL /mL[176] |
| Anti-phospholipid IgA | < 10[176] | 10–20[176] | 21–30[176] | > 31[176] | arb U/mL[176] |
| Anti-citrullinated protein antibodies | < 20[176] | 20–39[176] | 40–59[176] | > 60[176] | EU[176] |
Other immunology
| Test | Lower limit | Upper limit | Unit |
|---|---|---|---|
| Serum free light chains (FLC): kappa/lambda ratio | 0.26[178] | 1.65[178] | (unitless) |
Other enzymes and proteins
| Test | Lower limit | Upper limit | Unit | Comments |
|---|---|---|---|---|
| Serum total protein | 60,[21] 63[22] | 78,[21] 82,[22] 84[30] | g/L | Template:Further |
| Template:Anchor Lactate dehydrogenase (LDH) | 50[30] | 150[30] | U/L | |
| 0.4[61] | 1.7[61] | μmol/L | ||
| 1.8[10] | 3.4[10] | μkat/L | < 70 years old[10] | |
| Amylase | 25,[21] 30,[22] 53[30] | 110,[22] 120,[179] 123,[30] 125,[21] 190[61] | U/L | |
| 0.15[10] | 1.1[10] | μkat/L | ||
| 200[167] | 240[167] | nmol/L | ||
| D-dimer Template:Hatnote |
n/a | 500[180] | ng/mL | Higher in pregnant women[181] |
| 0.5[10] | mg/L | |||
| Lipase | 7,[22] 10,[30] 23[61] | 60,[22] 150,[30] 208[61] | U/L | |
| Angiotensin-converting enzyme (ACE) | 23[61] | 57[61] | U/L | |
| Acid phosphatase | 3.0[61] | ng/mL | ||
| Eosinophil cationic protein (ECP) | 2.3[10] | 16[10] | μg/L |
Other electrolytes and metabolites
Electrolytes and metabolites: For iron and copper, some related proteins are also included.
| Test | Patient type | Lower limit | Upper limit | Unit | Comments |
|---|---|---|---|---|---|
| Osmolality | 275,[21] 280,[30] 281[10] | 295,[21] 296,[30] 297[10] | mOsm/kg | Plasma weight excludes solutes | |
| Osmolarity | Slightly less than osmolality | mOsm/L | Plasma volume includes solutes | ||
| Urea | 3.0[182] | 7.0[182] | mmol/L | BUN – blood urea nitrogen | |
| 7[21] | 18,[21] 21[22] | mg/dL | |||
| * Uric acid[22] | 0.18[21] | 0.48[21] | mmol/L | ||
| Female | 2.0[30] | 7.0[30] | mg/dL | ||
| Male | 2.1[30] | 8.5[30] | mg/dL | ||
| Creatinine | Male | 60,[10] 68[183] | 90,[10] 118[183] | μmol/L | May be complemented with creatinine clearance |
| 0.7,[184] 0.8[184] | 1.0,[184] 1.3[184] | mg/dL | |||
| Female | 50,[10] 68[183] | 90,[10] 98[183] | μmol/L | ||
| 0.6,[184] 0.8[184] | 1.0,[184] 1.1[184] | mg/dL | |||
| BUN/Creatinine Ratio | 5[30] | 35[30] | – | ||
| Template:Anchor Plasma glucose (fasting) | 3.8,[21] 4.0[10] | 6.0,[10] 6.1[185] | mmol/L | See also glycated hemoglobin (in hematology) | |
| 65,[22] 70,[21] 72[186] | 100,[185] 110[30] | mg/dL | |||
| Full blood glucose (fasting) | 3.3[10] | 5.6[10] | mmol/L | ||
| 60[186] | 100[186] | mg/dL | |||
| Random glucose | 3.9[187] | 7.8[187] | mmol/L | ||
| 70[188] | 140[188] | mg/dL | |||
| Template:Anchor Lactate (Venous) | 4.5[30] | 19.8[30] | mg/dL | ||
| 0.5[189] | 2.2[189] | mmol/L | |||
| Lactate (Arterial) | 4.5[30] | 14.4[30] | mg/dL | ||
| 0.5[189] | 1.6[189] | mmol/L | |||
| Pyruvate | 300[30] | 900[30] | μg/dL | ||
| 34[190] | 102[190] | μmol/L | |||
| Ketones | 1[191] | mg/dL | |||
| 0.1[191] | mmol/L | ||||
Medication
| Test | Lower limit | Upper limit | Unit | Comments |
|---|---|---|---|---|
| Digoxin | 0.5[192] | 2.0[192] | ng/mL | Narrow therapeutic window |
| 0.6[192] | 2.6[192] | nmol/L | ||
| Lithium | 0.4,[193] 0.5,[194][195] 0.8[196] | 1.3[194][195] | mmol/L | Narrow therapeutic window |
| Paracetamol | 30[197] | mg/L | Risk of paracetamol toxicity at higher levels | |
| 200[197] | μmol/L |
See also
- Cardiology diagnostic tests and procedures
- Comprehensive metabolic panel
- Medical technologist
- Reference range
Notes
References
External links
Further reading
Template:Blood tests Template:Authority control
- ↑ Template:Cite journal
- ↑ Template:Cite journal
- ↑ Template:Cite journal
- ↑ Template:Cite web
- ↑ Template:Cite book
- ↑ Template:Cite journal
- ↑ Template:Cite web
- ↑ Template:Cite journal
- ↑ Template:Cite book
- ↑ 10.000 10.001 10.002 10.003 10.004 10.005 10.006 10.007 10.008 10.009 10.010 10.011 10.012 10.013 10.014 10.015 10.016 10.017 10.018 10.019 10.020 10.021 10.022 10.023 10.024 10.025 10.026 10.027 10.028 10.029 10.030 10.031 10.032 10.033 10.034 10.035 10.036 10.037 10.038 10.039 10.040 10.041 10.042 10.043 10.044 10.045 10.046 10.047 10.048 10.049 10.050 10.051 10.052 10.053 10.054 10.055 10.056 10.057 10.058 10.059 10.060 10.061 10.062 10.063 10.064 10.065 10.066 10.067 10.068 10.069 10.070 10.071 10.072 10.073 10.074 10.075 10.076 10.077 10.078 10.079 10.080 10.081 10.082 10.083 10.084 10.085 10.086 10.087 10.088 10.089 10.090 10.091 10.092 10.093 10.094 10.095 10.096 10.097 10.098 10.099 10.100 10.101 10.102 10.103 10.104 10.105 10.106 10.107 10.108 10.109 10.110 10.111 10.112 10.113 10.114 10.115 10.116 10.117 10.118 10.119 10.120 10.121 10.122 10.123 10.124 10.125 10.126 Reference range list from Uppsala University Hospital ("Laborationslista"). Artnr 40284 Sj74a. Issued on April 22, 2008
- ↑ Template:Cite journal
- ↑ Template:Cite web
- ↑ 13.0 13.1 13.2 Template:Cite magazine
- ↑ 14.0 14.1 14.2 14.3 14.4 Template:Cite web Updated: Jan 14, 2015
- ↑ 15.0 15.1 15.2 15.3 Template:Cite journal
- ↑ 16.0 16.1 16.2 16.3 Template:Cite journal
- ↑ Template:Cite journal
- ↑ Template:Cite journal
- ↑ Template:Cite journal
- ↑ PROOPIOMELANOCORTIN; NCBI / POMC Retrieved on September 28, 2009
- ↑ 21.000 21.001 21.002 21.003 21.004 21.005 21.006 21.007 21.008 21.009 21.010 21.011 21.012 21.013 21.014 21.015 21.016 21.017 21.018 21.019 21.020 21.021 21.022 21.023 21.024 21.025 21.026 21.027 21.028 21.029 21.030 21.031 21.032 21.033 21.034 21.035 21.036 21.037 21.038 21.039 21.040 21.041 21.042 21.043 21.044 21.045 21.046 21.047 21.048 21.049 21.050 21.051 21.052 21.053 21.054 21.055 21.056 21.057 21.058 21.059 21.060 21.061 21.062 21.063 21.064 21.065 21.066 21.067 21.068 21.069 21.070 21.071 21.072 21.073 21.074 21.075 21.076 21.077 21.078 21.079 21.080 21.081 21.082 21.083 21.084 21.085 21.086 21.087 21.088 21.089 21.090 21.091 21.092 21.093 21.094 21.095 21.096 21.097 21.098 21.099 21.100 21.101 21.102 21.103 21.104 21.105 21.106 21.107 Last page of Template:Cite book
- ↑ 22.000 22.001 22.002 22.003 22.004 22.005 22.006 22.007 22.008 22.009 22.010 22.011 22.012 22.013 22.014 22.015 22.016 22.017 22.018 22.019 22.020 22.021 22.022 22.023 22.024 22.025 22.026 22.027 22.028 22.029 22.030 22.031 22.032 22.033 22.034 22.035 22.036 22.037 22.038 22.039 22.040 22.041 22.042 22.043 22.044 22.045 22.046 22.047 22.048 22.049 22.050 22.051 22.052 22.053 22.054 22.055 22.056 22.057 22.058 22.059 22.060 22.061 22.062 22.063 22.064 22.065 22.066 22.067 22.068 22.069 22.070 22.071 22.072 22.073 22.074 22.075 22.076 22.077 22.078 22.079 22.080 22.081 22.082 22.083 22.084 22.085 22.086 22.087 22.088 22.089 22.090 22.091 22.092 22.093 22.094 22.095 22.096 22.097 22.098 22.099 22.100 22.101 22.102 22.103 22.104 22.105 Normal Reference Range Table Template:Webarchive from The University of Texas Southwestern Medical Center at Dallas. Used in Interactive Case Study Companion to Pathologic basis of disease.
- ↑ 23.0 23.1 23.2 23.3 Derived from molar values using molar mass of 22.99 g•mol−1
- ↑ 24.0 24.1 Derived from molar values using molar mass of 39.10 g•mol−1
- ↑ 25.00 25.01 25.02 25.03 25.04 25.05 25.06 25.07 25.08 25.09 25.10 25.11 25.12 Merck Manuals > Common Medical Tests > Blood Tests Last full review/revision February 2003
- ↑ 26.0 26.1 Derived from molar values using molar mass of 35.45 g•mol−1
- ↑ 27.0 27.1 Template:Cite journal
- ↑ 28.0 28.1 28.2 28.3 Derived from molar values using molar mass of 40.08 g•mol−1
- ↑ 29.0 29.1 29.2 Derived from mass values using molar mass of 40.08 g•mol−1
- ↑ 30.00 30.01 30.02 30.03 30.04 30.05 30.06 30.07 30.08 30.09 30.10 30.11 30.12 30.13 30.14 30.15 30.16 30.17 30.18 30.19 30.20 30.21 30.22 30.23 30.24 30.25 30.26 30.27 30.28 30.29 30.30 30.31 30.32 30.33 30.34 30.35 30.36 30.37 30.38 30.39 30.40 30.41 30.42 30.43 30.44 30.45 30.46 30.47 30.48 30.49 30.50 30.51 30.52 30.53 30.54 30.55 30.56 30.57 30.58 30.59 30.60 30.61 30.62 30.63 30.64 30.65 30.66 30.67 30.68 30.69 30.70 30.71 30.72 30.73 30.74 30.75 30.76 30.77 Blood Test Results – Normal Ranges Template:Webarchive Bloodbook.Com
- ↑ 31.00 31.01 31.02 31.03 31.04 31.05 31.06 31.07 31.08 31.09 31.10 31.11 Template:Cite web
- ↑ 32.0 32.1 32.2 32.3 Diagnostic Chemicals Limited > Serum Iron-SL Assay Template:Webarchive July 15, 2005
- ↑ 33.00 33.01 33.02 33.03 33.04 33.05 33.06 33.07 33.08 33.09 33.10 33.11 33.12 Derived from mass values using molar mass of 55.85 g•mol−1
- ↑ 34.0 34.1 Table 1. Page 133" Clinical Chemistry 45, No. 1, 1999 (stating 1.9–3.3 g/L)
- ↑ 35.0 35.1 Derived by dividing mass values with molar mass
- ↑ 36.0 36.1 36.2 36.3 Ferritin by: Mark Levin, MD, Hematologist and Oncologist, Newark, NJ. Review provided by VeriMed Healthcare Network
- ↑ 37.0 37.1 Template:Cite web Updated: Jan 02, 2016
- ↑ 38.0 38.1 38.2 38.3 38.4 Derived from mass values using molar mass of 450,000 g•mol−1
- ↑ 39.0 39.1 Template:Cite journal
- ↑ 40.0 40.1 Template:Cite journal
- ↑ 41.0 41.1 41.2 41.3 Derived from molar values using molar mass of 17.03 g/mol
- ↑ 42.0 42.1 Derived from mass values using molar mass of 63.55 g•mol−1
- ↑ Template:Cite GPnotebook
- ↑ 44.0 44.1 Derived from mass using molar mass of 151kDa
- ↑ Template:Cite book
- ↑ 46.0 46.1 Template:Cite web
- ↑ 47.0 47.1 Derived from molar values using molar mass of 65.38 g/mol
- ↑ 48.0 48.1 Derived from mass values using molar mass of 65.38 g/mol
- ↑ 49.0 49.1 Derived from molar values using molar mass of 24.31 g/mol
- ↑ 50.0 50.1 Derived from mass values using molar mass of 24.31 g/mol
- ↑ Template:Cite journal
- ↑ 52.00 52.01 52.02 52.03 52.04 52.05 52.06 52.07 52.08 52.09 52.10 52.11 The Medical Education Division of the Brookside Associates / ABG (Arterial Blood Gas) Retrieved on Dec 6, 2009
- ↑ 53.0 53.1 Derived from molar values using molar mass of 1.01 g•mol−1
- ↑ 54.0 54.1 54.2 54.3 54.4 54.5 54.6 54.7 Derived from mmHg values using 0.133322 kPa/mmHg
- ↑ 55.0 55.1 Derived from molar values using molar mass of 44.010 g/mol
- ↑ 56.0 56.1 56.2 56.3 Derived from molar values using molar mass of 61 g/mol
- ↑ Template:Cite GPnotebook
- ↑ 58.0 58.1 Derived from mass using molecular weight of 65kD
- ↑ 59.0 59.1 59.2 59.3 59.4 Derived from mass values using molar mass of 585g/mol
- ↑ 60.0 60.1 Derived from molar values using molar mass of 585g/mol
- ↑ 61.00 61.01 61.02 61.03 61.04 61.05 61.06 61.07 61.08 61.09 61.10 61.11 61.12 61.13 61.14 61.15 61.16 61.17 61.18 Fachwörterbuch Kompakt Medizin E-D/D-E. Author: Fritz-Jürgen Nöhring. Edition 2. Publisher:Elsevier, Urban&FischerVerlag, 2004. Template:ISBN. Length: 1288 pages
- ↑ 62.0 62.1 62.2 62.3 GPnotebook > reference range (AST) Template:Webarchive Retrieved on Dec 7, 2009
- ↑ 63.0 63.1 Template:Cite web
- ↑ 64.0 64.1 Template:Cite GPnotebook
- ↑ 65.0 65.1 65.2 65.3 Page 585 in: Template:Cite book
- ↑ 66.0 66.1 66.2 66.3 Muscle Information and Courses from MediaLab, Inc. > Cardiac Biomarkers Retrieved on April 22, 2010
- ↑ Template:Cite journal
- ↑ Template:Cite journal
- ↑ 69.0 69.1 Page 220 in: Template:Cite book
- ↑ 70.00 70.01 70.02 70.03 70.04 70.05 70.06 70.07 70.08 70.09 70.10 70.11 70.12 70.13 Adëeva Nutritionals Canada > Optimal blood test values Template:Webarchive Retrieved on July 9, 2009
- ↑ 71.0 71.1 71.2 71.3 71.4 71.5 Derived from values in mg/dL to mmol/L, by dividing by 89, according to faqs.org: What are mg/dL and mmol/L? How to convert? Glucose? Cholesterol? Last Update July 21, 2009. Retrieved on July 21, 2009
- ↑ 72.0 72.1 72.2 72.3 Derived from values in mg/dL to mmol/L, using molar mass of 386.65 g/mol
- ↑ 73.0 73.1 73.2 Template:Cite GPnotebook
- ↑ 74.0 74.1 74.2 74.3 74.4 74.5 74.6 74.7 Royal College of Pathologists of Australasia; Cholesterol (HDL and LDL) – plasma or serum Last Updated: Monday, 6 August 2007
- ↑ 75.00 75.01 75.02 75.03 75.04 75.05 75.06 75.07 75.08 75.09 Derived from values in mmol/L, using molar mass of 386.65 g/mol
- ↑ What Your Cholesterol Levels Mean. American Heart Association. Retrieved on September 12, 2009
- ↑ Template:Cite web
- ↑ GP Notebook > range (reference, ca-125) Retrieved on Jan 5, 2009
- ↑ ClinLab Navigator > Test Interpretations > CA-125 Template:Webarchive Retrieved on March 8, 2011
- ↑ 80.0 80.1 Template:Cite journal
- ↑ Carcinoembryonic Antigen(CEA) at MedicineNet
- ↑ 82.0 82.1 82.2 Template:Cite journal
- ↑ 83.0 83.1 83.2 Template:Cite journal
- ↑ The TSH Reference Range Wars: What's "Normal?", Who is Wrong, Who is Right... Template:Webarchive By Mary Shomon, About.com. Updated: June 19, 2006. About.com Health's Disease and Condition
- ↑ 85.0 85.1 2006 Press releases: Thyroid Imbalance? Target Your Numbers Template:Webarchive Contacts: Bryan Campbell American] Association of Clinical Endocrinologists
- ↑ 86.0 86.1 The TSH Reference Range Wars: What's "Normal?", Who is Wrong, Who is Right... Template:Webarchive By Mary Shomon, About.com. Updated: June 19, 2006
- ↑ 87.0 87.1 Template:Cite web – see Section 2. Pre-analytic factors
- ↑ 88.0 88.1 88.2 88.3 88.4 88.5 Free T4; Thyroxine, Free; T4, Free Template:Webarchive UNC Health Care System
- ↑ Derived from molar values using molar mass of 776.87 g/mol
- ↑ 90.0 90.1 90.2 90.3 90.4 90.5 Derived from mass values using molar mass of 776.87 g/mol
- ↑ 91.00 91.01 91.02 91.03 91.04 91.05 91.06 91.07 91.08 91.09 91.10 91.11 91.12 91.13 91.14 Table 4: Typical reference ranges for serum assays Template:Webarchive – Thyroid Disease Manager
- ↑ 92.0 92.1 92.2 92.3 Template:Cite journal
- ↑ 93.0 93.1 93.2 93.3 Derived from mass values using molar mass of 650.98 g/mol
- ↑ 94.0 94.1 Template:Cite journal
- ↑ Template:Cite journal
- ↑
- ↑
- ↑ 98.0 98.1 Template:Cite web
- ↑ 99.0 99.1 99.2 99.3 Derived from mass values using molar mass of 288.42g/mol
- ↑ 100.0 100.1 100.2 100.3 100.4 100.5 100.6 Derived from molar values using molar mass of 288.42g/mol
- ↑ 101.0 101.1 101.2 101.3 MedlinePlus > Testosterone Update Date: 3/18/2008. Updated by: Elizabeth H. Holt, MD, PhD, Yale University. Review provided by VeriMed Healthcare Network. Also reviewed by David Zieve, MD, MHA, Medical Director
- ↑ 102.0 102.1 102.2 102.3 Derived from mass values using molar mass of 330.46g/mol
- ↑ 103.00 103.01 103.02 103.03 103.04 103.05 103.06 103.07 103.08 103.09 reference range (FSH) GPnotebook. Retrieved on September 27, 2009
- ↑ 104.0 104.1 104.2 104.3 104.4 104.5 Values taken from day 1 after LH surge in: Template:Cite journal
- ↑ 105.0 105.1 105.2 105.3 105.4 105.5 New York Hospital Queens > Services and Facilities > Patient Testing > Pathology > New York Hospital Queens Diagnostic Laboratories > Test Directory > Reference RangesTemplate:Dead link Retrieved on Nov 8, 2009
- ↑ 106.0 106.1 Mayo Medical Laboratories > Test ID: LH, Luteinizing Hormone (LH), Serum Template:Webarchive, retrieved December 2012
- ↑ 107.0 107.1 107.2 107.3 107.4 107.5 107.6 GPNotebook – reference range (oestradiol) Template:Webarchive Retrieved on September 27, 2009
- ↑ 108.0 108.1 108.2 108.3 108.4 108.5 108.6 Derived from molar values using molar mass of 272.38g/mol
- ↑ 109.0 109.1 109.2 109.3 Total amount multiplied by 0.022 according to 2.2% presented in: Template:Cite journal
- ↑ 110.0 110.1 Derived from mass values using molar mass of 314.46 g/mol
- ↑ 111.0 111.1 Bhattacharya Sudhindra Mohan (July/August 2005) Mid-luteal phase plasma progesterone levels in spontaneous and clomiphene citrate induced conception cycles Template:Webarchive J Obstet Gynecol India Vol. 55, No. 4 : July/August 2005 pp. 350–52
- ↑ 112.0 112.1 Dehydroepiandrosterone Sulfate (DHEA-S), Serum Template:Webarchive at Mayo Foundation For Medical Education And Research. Retrieved July 2012
- ↑ 113.0 113.1 113.2 113.3 Unit Code 91215 Template:Webarchive at Mayo Clinic Medical Laboratories. Retrieved April 2011
- ↑ 114.0 114.1 Antimullerian Hormone (AMH), Serum Template:Webarchive from Mayo Medical Laboratories. Retrieved April 2012.
- ↑ 115.0 115.1 Derived from mass values using 140,000 g/mol, as given in:
- ↑ 116.0 116.1 Template:Cite web
- ↑ 117.0 117.1 117.2 117.3 Biochemistry Reference Ranges at Good Hope Hospital Template:Webarchive Retrieved on Nov 8, 2009
- ↑ 118.0 118.1 118.2 118.3 Derived from molar values using molar mass of 362 g/mol
- ↑ 119.0 119.1 119.2 119.3 119.4 119.5 119.6 119.7 Template:Cite journal
- ↑ 120.00 120.01 120.02 120.03 120.04 120.05 120.06 120.07 120.08 120.09 120.10 120.11 120.12 120.13 120.14 120.15 Taken from the assay method giving the lowest and highest estimate, respectively, from Table 2 in: Template:Cite journal
- ↑ 121.0 121.1 Derived from molar values using molar mass of 9.4 kDa
- ↑ 122.0 122.1 Table 2 in: Template:Cite journal
- ↑ 123.0 123.1 Derived from mass values using molar mass of 9.4 kDa
- ↑ 124.0 124.1 124.2 124.3 124.4 124.5 Derived from molar values using molar mass 400.6 g/mol
- ↑ 125.0 125.1 125.2 125.3 Template:Cite book Retrieved December 10, 2008 through Google Book Search.
- ↑ 126.0 126.1 126.2 126.3 Template:Cite journal
- ↑ 127.0 127.1 127.2 127.3 Template:Cite journal
- ↑ 128.0 128.1 128.2 128.3 128.4 128.5 128.6 128.7 Template:Cite journal
- ↑ 129.0 129.1 Converted from values in mcU/mL by dividing with a factor of 11.2 mcU/mL per ng/(mL*hour), as given in: Washington, Department of Laboratory Medicine. Retrieved Mars 2011
- ↑ 130.0 130.1 Template:Cite journal
- ↑ 131.0 131.1 131.2 131.3 New Assays for Aldosterone, Renin and Parathyroid Hormone Template:Webarchive University of Washington, Department of Laboratory Medicine. Retrieved Mars 2011
- ↑ 132.0 132.1 Converted from values in ng/(mL*hour) by multiplying with a factor of 11.2 mcU/mL per ng/(mL*hour), as given in: Washington, Department of Laboratory Medicine. Retrieved Mars 2011
- ↑ 133.0 133.1 Converted from mass values using molar mass of 360.44 g/mol
- ↑ 134.0 134.1 134.2 134.3 Template:Cite journal
- ↑ 135.0 135.1 135.2 135.3 135.4 135.5 Central Manchester University Hospitals / Reference ranges Template:Webarchive Retrieved on July 9, 2009
- ↑ University of Kentucky Chandler Medical Center > Clinical Lab Reference Range Guide Retrieved on April 28, 2009
- ↑ 137.0 137.1 137.2 137.3 137.4 Derived from mass values using molar mass of 441 mol−1
- ↑ 138.0 138.1 GPnotebook > B12 Retrieved on April 28, 2009
- ↑ 139.0 139.1 Derived form molar values using molar mass of 1355g/mol
- ↑ 140.0 140.1 Derived from mass values using molar mass of 1355g/mol
- ↑ 141.0 141.1 141.2 141.3 Template:Cite web
- ↑ 142.0 142.1 142.2 142.3 Derived from molar values using molar massof 135 g/mol
- ↑ 143.0 143.1 Derived from mass values using molar mass of 176 grams per mol
- ↑ 144.0 144.1 144.2 For Driving under the influence by country, see Drunk driving law by country
- ↑ Derived from mass values using molar mass of 46g/mol
- ↑ 146.0 146.1 146.2 146.3 146.4 Derived from mass values using 64,500 g/mol. This molar mass was taken from: Template:Cite journal
- ↑ 147.0 147.1 147.2 147.3 Normal Lab Values Template:Webarchive at Marshall University Joan C. Edwards School of Medicine. Retrieved July 2013
- ↑ 148.0 148.1 148.2 148.3 148.4 148.5 148.6 148.7 molar concentration as given for hemoglobin above, but multiplied by 4, according to: Template:Cite journal
- ↑ 149.0 149.1 149.2 149.3 Derived from mass concentration, using molar mass of 64,458 g/mol. This molar mass was taken from: Template:Cite journal. Subsequently, 1 g/dL = 0.1551 mmol/L
- ↑ 150.0 150.1 150.2 150.3 150.4 150.5 Template:Cite journal
- ↑ 151.0 151.1 Template:Cite journal
- ↑ 152.0 152.1 152.2 152.3 152.4 152.5 152.6 152.7 lymphomation.org > Tests & Imaging > Labs > Complete Blood Count Retrieved on May 14, 2009
- ↑ 153.00 153.01 153.02 153.03 153.04 153.05 153.06 153.07 153.08 153.09 153.10 153.11 153.12 153.13 153.14 153.15 153.16 153.17 153.18 153.19 153.20 Template:Cite book
- ↑ "Determination of monocyte count by hematological analyzers, manual method and flow cytometry in Polish population" Central European Journal of Immunology (Centr Eur J Immunol 2006; 31 (1–2): 1–5) authors: Elżbieta Górska, Urszula Demkow, Roman Pińkowski, Barbara Jakubczak, Dorota Matuszewicz, Jolanta Gawęda, Wioletta Rzeszotarska, Maria Wąsik,
- ↑ 155.0 155.1 155.2 155.3 155.4 gpnotebook.co.uk > blood constituents (reference range) Retrieved on May 14, 2009
- ↑ 156.0 156.1 Template:Cite journal
- ↑ 157.0 157.1 Normal Values: RBC, Hgb, Hct, Indices, RDW, Platelets, and MPV (Conventional Units) Template:Webarchive From labcareplus. Retrieved 4 nov, 2010
- ↑ 158.0 158.1 Template:Cite journal
- ↑ 159.0 159.1 Template:MedlinePlusEncyclopedia
- ↑ 160.0 160.1 Template:EMedicine
- ↑ 161.0 161.1 Antithrombin CO000300 Template:Webarchive in Coagulation Test Handbook at Massachusetts General Hospital. In turn citing:
- Elizabeth M. Van Cott, M.D., and Michael Laposata, M.D., Ph.D., "Coagulation." In: Jacobs DS et al, ed. The Laboratory Test Handbook, 5th Edition. Lexi-Comp, Cleveland, 2001; 327–58.
- ↑ 162.0 162.1 Template:Cite web
- ↑ 163.0 163.1 Template:Cite journal
- ↑ Template:Cite journal
- ↑ Template:Cite GPnotebook
- ↑ 2730 Serum C-Reactive Protein values in Diabetics with Periodontal Disease Template:Webarchive A.R. Choudhury, and S. Rahman, Birdem, Diabetic Association of Bangladesh, Dhaka, Bangladesh. (the diabetics were not used to determine the reference ranges)
- ↑ 167.0 167.1 167.2 167.3 Derived from mass using molar mass of 25,106 g/mol
- ↑ 168.0 168.1 Template:Cite journal
- ↑ 169.0 169.1 Derived from mass values using molar mass of 44324.5 g/mol
- ↑ 170.0 170.1 Derived from molar values using molar mass of 44324.5 g/mol
- ↑ Template:Cite web
- ↑ 172.00 172.01 172.02 172.03 172.04 172.05 172.06 172.07 172.08 172.09 The Society for American Clinical Laboratory Science > Chemistry Tests > Immunoglobulins Template:Webarchive Retrieved on Nov 26, 2009
- ↑ 173.0 173.1 Template:Cite web
- ↑ 174.0 174.1 Template:Cite web
- ↑ 175.0 175.1 175.2 Template:Cite web
- ↑ 176.00 176.01 176.02 176.03 176.04 176.05 176.06 176.07 176.08 176.09 176.10 176.11 176.12 176.13 176.14 176.15 176.16 176.17 176.18 176.19 176.20 176.21 176.22 176.23 176.24 176.25 176.26 176.27 176.28 176.29 176.30 chronolab.com > Autoantibodies associated with rheumatic diseases > Reference ranges Template:Webarchive Retrieved on April 29, 2010
- ↑ 177.0 177.1 177.2 Template:Cite web
- ↑ 178.0 178.1 Template:Cite journal
- ↑ Template:Cite GPnotebook
- ↑ Template:Cite journal
- ↑ Template:Cite journal
- ↑ 182.0 182.1 Template:Cite journal
- ↑ 183.0 183.1 183.2 183.3 Template:Cite journal
- ↑ 184.0 184.1 184.2 184.3 184.4 184.5 184.6 184.7 Derived from molar values by multiplying with the molar mass of 113.118 g/mol, and divided by 10.000 to adapt from μg/L to mg/dL
- ↑ 185.0 185.1 Template:MedlinePlusEncyclopedia
- ↑ 186.0 186.1 186.2 Derived from molar values using molar mass of 180g/mol
- ↑ 187.0 187.1 Derived from mass values using molar mass of 180g/mol
- ↑ 188.0 188.1 Template:Cite web Last revised 1/15/2013
- ↑ 189.0 189.1 189.2 189.3 Derived from mass values using molar mass of 90.08 g/mol
- ↑ 190.0 190.1 Derived from mass values using molar mass of 88.06 g/mol
- ↑ 191.0 191.1 Template:EMedicine
- ↑ 192.0 192.1 192.2 192.3 Page 700 in:
Template:Cite book - ↑ The UK Electronic Medical Compendium recommends 0.4–0.8 mmol/L plasma lithium level in adults for prophylaxis of recurrent affective bipolar manic-depressive illness Camcolit 250 mg Lithium Carbonate Template:Webarchive Revision 2 December 2010, Retrieved 5 May 2011
- ↑ 194.0 194.1 Template:Cite journal
- ↑ 195.0 195.1 R. Baselt, Disposition of Toxic Drugs and Chemicals in Man, 8th edition, Biomedical Publications, Foster City, CA, 2008, pp. 851–54.
- ↑ One study (Template:Cite journal) concluded a "low" dose of 0.4–0.6 mmol/L serum lithium treatment for patients with bipolar 1 disorder had less side effects, but a higher rate of relapse, than a "standard" dose of 0.8–1.0 mmol/L. However, a reanalysis of the same experimental data (Template:Cite journal) concluded the higher rate of relapse for the "low" dose was due to abrupt changes in the lithium serum levelsTemplate:Synthesis inline
- ↑ 197.0 197.1 Template:Cite book
Cite error: <ref> tags exist for a group named "note", but no corresponding <references group="note"/> tag was found.